Ad hoc Announcement of Insider Information according to Article 17 MAR
QIAGEN intends to return capital of US$300 million to shareholders by end of 2017
Venlo, The Netherlands, July 28, 2016 – QIAGEN N.V. announces that it intends to return capital to its shareholders in the additional amount of approximately US$200 million by early 2017. Considering the share repurchase program announced on 27th April 2016 of up to a total of US$100 million, which has not yet been started, the total return figure is expected to be approximately US$300 million. Both the manner and structure and the exact timing of the capital return are still subject to the approval of QIAGEN’s Managing Board and Supervisory Board and will be announced separately at a later stage.
In addition, QIAGEN gives notice that the already announced repurchase program of up to US$100 million is now intended to be completed before the end of 2017. Details of the repurchase program will be announced before its actual commencement in line with Article 5 Section (1) and (6) of the EU regulation 596/2014 in conjunction with the regulatory technical standards adopted by the European Commission (so called Safe Harbour Regulation). Repurchased shares will be held in treasury in order to satisfy obligations for exchangeable debt instruments and employee share-based remuneration plans.
5912 PL Venlo
Frankfurt Stock Exchange, Regulated Market (Prime Standard)